Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Molecular Imaging and Biology|May 5, 2019
Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck CancerNaoki Nishio, Nynke S van den Berg, Stan van Keulen, et al.
Head & Neck|February 23, 2016
Consultation via telemedicine and access to operative care for patients with head and neck cancer in a Veterans Health Administration populationDaniel M Beswick, Anita Vashi, Yohan Song, et al.
Theranostics|May 4, 2018
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancersRebecca W Gao, Nutte Teraphongphom, Esther de Boer, et al.
Oral Oncology|September 17, 2013
Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinomaKristy A Warner, April Adams, Lisiane Bernardi, et al.
The Laryngoscope|March 31, 2012
Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?Matthew E Spector, Steven B Chinn, Andrew J Rosko, et al.
Head & Neck|December 3, 2009
Chemotherapy alone for organ preservation in advanced laryngeal cancerVasu Divi, Francis P Worden, Mark E Prince, et al.
Nature Communications|November 8, 2019
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancerNaoki Nishio, Nynke S van den Berg, Stan van Keulen, et al.
Head & Neck|October 2, 2019
Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessmentNaoki Nishio, Stan van Keulen, Nynke S van den Berg, et al.
Science Translational Medicine|May 6, 2026
CD39<sup>+</sup>CD49a<sup>+</sup>CD103<sup>+</sup> cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in miceNina B Horowitz, Imran A Mohammad, June Ho Shin, et al.
Head & Neck|August 3, 2022
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinomaJacob A Miller, Farshad Moradi, Vandana Sundaram, et al.
Pageof 10